CRHR2 and malignant colon neoplasm: Given the reduced expression of CRHR2 and its ligand UCN III in human colon cancer tissues, these findings indicate that the impairment of CRHR2-mediated responses should be associated with colon cancer development in humans, which may contribute to cancer metastasis or poor patient survival.